Main menu

Document repository

263 Results
Advancing clinical metagenomics for patient care in IndiaWebinar

Advancing clinical metagenomics for patient care in India

Explores how distributed clinical metagenomics could be implemented at a large scale across India, with insights that can extend to healthcare systems globally.

Decoding complex disease through multiomicsWebinar

Decoding complex disease through multiomics

In this webinar, our expert speakers will discuss how multiomic Oxford Nanopore sequencing supports a deeper understanding of disease mechanisms, by integrating DNA, RNA, and epigenetic analysis — all on a ...

Rapid and accurate pan-cancer subtyping using RNA-sequencingWebinar

Rapid and accurate pan-cancer subtyping using RNA-sequencing

Watch this on-demand webinar exploring how RNA sequencing is transforming childhood cancer diagnosis. Dr. Adam Shlien presents a multiscale transcriptomic atlas that matched or clarified diagnoses for 85% of ...

Exploring microbial methylationWebinar

Exploring microbial methylation

In this webinar we learn how to advance microbial genomics and epigenomics research with authenticated reference resources.

Which library prep workflow is right for my experiment?Event video

Which library prep workflow is right for my experiment?

Whether you’re sequencing DNA, RNA, or cDNA, a single sample or many in multiplex, there’s an Oxford Nanopore library prep kit for you. In this masterclass, discover how ...

Welcome to London Calling 2026 | LC26Event video

Welcome to London Calling 2026 | LC26

Francis Van Parys joined Oxford Nanopore Technologies as Chief Executive Officer in March 2026. He is an accomplished global life sciences executive with more than 20 years of leadership experience ...

Understanding the role of rRNA modifications in colorectal cancer | LC26Event video

Understanding the role of rRNA modifications in colorectal cancer | LC26

Beyond genetic mutations, post-transcriptional gene regulation through ribosomal RNA (rRNA) modifications represents a critical yet underexplored mechanism of tumor adaptation. These modifications, guided by small nucleolar RNAs (snoRNAs), generate ...

Understanding population-scale structural variation using long-read genomics | LC26Event video

Understanding population-scale structural variation using long-read genomics | LC26

Understanding structural variation (SV) across human populations and disease contexts requires both comprehensive sequencing and analytical frameworks that capture genomic complexity. This talk presents our recent work applying Oxford Nanopore ...

Third-generation homozygosity analysis | LC26Event video

Third-generation homozygosity analysis | LC26

Runs of homozygosity (ROH) are extended chromosomal regions of consecutive homozygous genotypes arising from demographic history and recent parental relatedness through identity by descent (IBD), or from mitotic recombination events ...

Targeted nanopore sequencing for newborn screening in a small population | LC26Event video

Targeted nanopore sequencing for newborn screening in a small population | LC26

Newborn screening (NBS) is a cornerstone of public health, originally established around biochemical detection of phenylketonuria and later expanded to include additional metabolic and genetic disorders. However, implementation of molecular ...

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditation

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

English flag